Literature DB >> 24837058

Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.

Lisa Buchy1, Diana Perkins2, Scott W Woods3, Lu Liu1, Jean Addington4.   

Abstract

Elevated rates of substance use (alcohol, tobacco, cannabis) have been reported in people at clinical high risk (CHR) of developing psychosis and there is some evidence that substance use may be higher in those who convert to a psychosis compared to non-converters. However little is known about the predictive value of substance use on risk of conversion to psychosis in those at CHR of psychosis. In the current study, 170 people at CHR of psychosis were assessed at baseline on severity of alcohol, tobacco and cannabis using the Alcohol and Drug Use Scale. Participants were recruited across three sites over a four year period as part of the Enhancing the Prospective Prediction of Psychosis (PREDICT) study. Predictors of conversion to psychosis were examined using Cox proportional hazards models. Results revealed that low use of alcohol, but neither cannabis use nor tobacco use at baseline, contributed to the prediction of psychosis in the CHR sample. Prediction algorithms incorporating combinations of additional baseline variables known to be associated with psychotic conversion may result in increased predictive power compared with substance use alone.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Cannabis; Prodrome; Psychosis; Substance use; Tobacco

Mesh:

Year:  2014        PMID: 24837058      PMCID: PMC4082820          DOI: 10.1016/j.schres.2014.04.021

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

1.  Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study.

Authors:  Andrew Thompson; Barnaby Nelson; Alison Yung
Journal:  Schizophr Res       Date:  2010-10-29       Impact factor: 4.939

2.  Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.

Authors:  Cheryl M Corcoran; David Kimhy; Arielle Stanford; Shamir Khan; Julie Walsh; Judy Thompson; Scott Schobel; Jill Harkavy-Friedman; Ray Goetz; Tiziano Colibazzi; Victoria Cressman; Dolores Malaspina
Journal:  Schizophr Res       Date:  2008-09-21       Impact factor: 4.939

3.  Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group.

Authors:  Lisa J Phillips; Christina Curry; Alison R Yung; Hok Pan Yuen; Steven Adlard; Patrick D McGorry
Journal:  Aust N Z J Psychiatry       Date:  2002-12       Impact factor: 5.744

4.  Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

Authors:  S Sevy; D G Robinson; S Holloway; J M Alvir; M G Woerner; R Bilder; R Goldman; J Lieberman; J Kane
Journal:  Acta Psychiatr Scand       Date:  2001-11       Impact factor: 6.392

5.  Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.

Authors:  Nikie Korver; Dorien H Nieman; Hiske E Becker; J Reinaud van de Fliert; Peter H Dingemans; Lieuwe de Haan; Mark Spiering; Nicole Schmitz; Don H Linszen
Journal:  Aust N Z J Psychiatry       Date:  2010-03       Impact factor: 5.744

6.  Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Authors:  A M Auther; D McLaughlin; R E Carrión; P Nagachandran; C U Correll; B A Cornblatt
Journal:  Psychol Med       Date:  2012-04-30       Impact factor: 7.723

7.  Cannabis abuse and risk for psychosis in a prodromal sample.

Authors:  Karin Kristensen; Kristin S Cadenhead
Journal:  Psychiatry Res       Date:  2007-03-26       Impact factor: 3.222

8.  Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Markus Heinimaa; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Georg Juckel; Andreas Heinz; Anthony Morrison; Shôn Lewis; Heinrich Graf von Reventlow; Joachim Klosterkötter
Journal:  Arch Gen Psychiatry       Date:  2010-03

9.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

10.  Substance use in a population-based clinic sample of people with first-episode psychosis.

Authors:  Jennifer H Barnett; Ursula Werners; Sandra M Secher; Katherine E Hill; Rossa Brazil; Kim Masson; David E Pernet; James B Kirkbride; Graham K Murray; Ed T Bullmore; Peter B Jones
Journal:  Br J Psychiatry       Date:  2007-06       Impact factor: 9.319

View more
  11 in total

1.  The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.

Authors:  Jean Addington; Lu Liu; Diana O Perkins; Ricardo E Carrion; Richard S E Keefe; Scott W Woods
Journal:  Schizophr Bull       Date:  2016-10-25       Impact factor: 9.306

Review 2.  Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review.

Authors:  Megan S Farris; Mohammed K Shakeel; Jean Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-03       Impact factor: 4.328

Review 3.  Cannabis and Psychosis: a Critical Overview of the Relationship.

Authors:  Charles Ksir; Carl L Hart
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

4.  The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2017-05-30       Impact factor: 4.905

5.  Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.

Authors:  Ariel Schvarcz; Carrie E Bearden
Journal:  Curr Behav Neurosci Rep       Date:  2015-01-18

6.  Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.

Authors:  A M Auther; K S Cadenhead; R E Carrión; J Addington; C E Bearden; T D Cannon; T H McGlashan; D O Perkins; L Seidman; M Tsuang; E F Walker; S W Woods; B A Cornblatt
Journal:  Acta Psychiatr Scand       Date:  2015-01-09       Impact factor: 6.392

7.  Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.

Authors:  R Carney; J Cotter; J Firth; T Bradshaw; A R Yung
Journal:  Acta Psychiatr Scand       Date:  2017-02-07       Impact factor: 6.392

Review 8.  Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.

Authors:  André Schmidt; Marco Cappucciati; Joaquim Radua; Grazia Rutigliano; Matteo Rocchetti; Liliana Dell'Osso; Pierluigi Politi; Stefan Borgwardt; Thomas Reilly; Lucia Valmaggia; Philip McGuire; Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

9.  Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature.

Authors:  Athanasios Gogos; Maria Skokou; Eleni Ferentinou; Philippos Gourzis
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-16       Impact factor: 2.570

Review 10.  Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review.

Authors:  Cristiana Montemagni; Silvio Bellino; Nadja Bracale; Paola Bozzatello; Paola Rocca
Journal:  Front Psychiatry       Date:  2020-03-24       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.